$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] The effect of new compounds in stabilizing downstream monoclonal antibody (mAb) process intermediates

International journal of pharmaceutics, v.565, 2019년, pp.162 - 173  

Ramos, Irina (Purification Process Sciences Department, Medimmune LLC, One Medimmune Way) ,  Lourenço, Eva C. (Extremochem) ,  Ascenso, Osvaldo S. (Extremochem) ,  Maycock, Christopher D. (Faculdade de Ciê) ,  Dasika, Madhukar (ncias da Universidade de Lisboa, Departamento de Quí) ,  Dickson, Matthew L. (mica e Bioquí) ,  Ventura, M. Rita (mica)

Abstract AI-Helper 아이콘AI-Helper

Abstract Determining the stability of downstream process (DSP) intermediates is an extremely important parameter used to maintain product quality attributes within their acceptance ranges. The IgG4 monoclonal antibody studied (mAb1) showed aggregation under acidic conditions, inhibiting the use of ...

Keyword

참고문헌 (33)

  1. Biochemistry Baynes 44 12 4919 2005 10.1021/bi047528r Role of arginine in the stabilization of proteins against aggregation 

  2. Nat. Rev. Immunol. Beck 10 345 2010 10.1038/nri2747 Strategies and challenges for the next generation of therapeutic antibodies 

  3. J. Membr. Sci. Bolton 277 1-2 75 2006 10.1016/j.memsci.2004.12.053 Combined models of membrane fouling: development and application to microfiltration and ultrafiltration of biological fluids 

  4. Biotechnol. Prog. Bolton 26 6 1671 2010 10.1002/btpr.494 Achieving high mass-throughput of therapeutic proteins through parvovirus retentive filters 

  5. J. Mol. Biol. Briehl 123 4 521 1978 10.1016/0022-2836(78)90205-X Gelation of sickle cell hemoglobin. IV. Phase transitions in hemoglobin S gels: separate measures of aggregation and solution-gel equilibrium 

  6. MAbs Buchanan 5 2 255 2013 10.4161/mabs.23392 Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression 

  7. Biochemistry Buchner 30 6922 1991 10.1021/bi00242a016 Alternatively folded states of an immunoglobulin 

  8. Step. BioProcess Int. De Souza 4 2016 Virus-filtration process development optimization the key to a more efficient and cost-effective 

  9. Proteins Ejima 66 954 2007 10.1002/prot.21243 Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies 

  10. Biotechnol. Genet. Eng. Rev. Fahrner 18 1 301 2001 10.1080/02648725.2001.10648017 Industrial purification of pharmaceutical antibodies: development, operation, and validation of chromatography processes 

  11. Biochemistry Fink 33 12504 1994 10.1021/bi00207a018 Classification of acid denaturation of proteins: intermediates and unfolded states 

  12. Biochemistry Gekko 20 16 4667 1981 10.1021/bi00519a023 Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures 

  13. Biochemistry Gekko 20 16 4677 1981 10.1021/bi00519a024 Thermodynamic and kinetic examination of protein stabilization by glycerol 

  14. Eur. J. Pharm. Sci. Hawe 38 2 79 2009 10.1016/j.ejps.2009.06.001 Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress 

  15. J. Pharm. Sci. He 99 4 1707 2010 10.1002/jps.21955 High throughput thermostability screening of monoclonal antibody formulations 

  16. J. Phys. Chem. B Kamerzell 112 110 3240 2008 10.1021/jp710061a Immunoglobulin dynamics, conformational fluctuations, and nonlinear elasticity and their effects on stability 

  17. Adv. Drug. Deliv. Rev. Kamerzell 63 13 1118 2011 10.1016/j.addr.2011.07.006 Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development 

  18. Curr. Pharm. Biotechnol. Koren 3 349 2002 10.2174/1389201023378175 Immune responses to therapeutic proteins in humans-clinical significance, assessment and prediction 

  19. Int. J. Pharm. Kumar 413 1-2 19 2011 10.1016/j.ijpharm.2011.04.011 Modulation of the thermodynamic stability of proteins by polyols: significance of polyol hydrophobicity and impact on the chemical potential of water 

  20. Pharm. Res. Kumar 31 11 3161 2014 10.1007/s11095-014-1409-0 Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties 

  21. J. Biol. Chem. Latypov 287 1381 2012 10.1074/jbc.M111.297697 Elucidation of acid-induced unfolding and aggregation of human immunoglobulin IgG1 and IgG2 Fc 

  22. FEBS Lett. Lilie 362 1 43 1995 10.1016/0014-5793(95)00203-L Domain interactions stabilize the alternatively folded state of an antibody Fab fragment 

  23. Eur. J. Pharm. Biopharm. Maarschalkerweerd 78 2 213 2011 10.1016/j.ejpb.2011.01.012 Comparison of analytical methods to detect instability of etanercept during thermal stress testing 

  24. Maycock, C.D., Ventura, M.R., Lourenco, E.C., Santos, M.H.D.S., Miguel, A.S.C., 2015. Hexose derivatives, preparation and uses thereof. WO 2015137838A1, September 17. 

  25. J. Biomol. Screen. Niedziela-Majka 20 4 552 2015 10.1177/1087057114557781 High-throughput screening of formulations to optimize the thermal stability of a therapeutic monoclonal antibody 

  26. Eur. J. Pharm. Sci. Oyetayo 97 151 2017 10.1016/j.ejps.2016.11.016 Diversity selection, screening and quantitative structure-activity relationships of osmolyte-like additive effects on the thermal stability of a monoclonal antibody 

  27. Adv. Protein. Chem. Ptitsyn 47 83 1995 10.1016/S0065-3233(08)60546-X Molten globule and protein folding 

  28. Nat. Immunol. Reth 14 8 765 2013 10.1038/ni.2621 Matching cellular dimensions with molecular sizes 

  29. AAPS J. Rosenberg 8 3 E501 2006 10.1208/aapsj080359 Effects of protein aggregates: an immunologic perspective 

  30. Pharm. Res. Saito 30 5 1263 2013 10.1007/s11095-012-0965-4 Effects of ionic strength and sugars on the aggregation propensity of monoclonal antibodies: influence of colloidal and conformational stabilities 

  31. Biochemistry Sarkar-Banerjee 55 4457 2016 10.1021/acs.biochem.6b00390 The non-native helical intermediate state may accumulate at low pH in the folding and aggregation landscape of the intestinal fatty acid binding protein 

  32. J. Mol. Biol. Thies 309 1077 2001 10.1006/jmbi.2001.4707 The alternatively folded state of the antibody C(H)3 domain 

  33. J. Colloid. Interface Sci. Wang 328 2 464 2008 10.1016/j.jcis.2008.09.028 Pore blocking mechanisms during early stages of membrane fouling by colloids 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로